ZA200006567B - Gene coding for heliomicine and use thereof. - Google Patents

Gene coding for heliomicine and use thereof. Download PDF

Info

Publication number: ZA200006567B
Authority: ZA; South Africa
Prior art keywords: peptide; sequence; heliomicine; amino; gene
Prior art date: 1998-04-15

Application number

ZA200006567A

Other languages

English (en)

Inventor

Mireille Lamberty

Philippe Bulet

Gary Lee Brookhart

Jules Hofmann

Original Assignee

Aventis Cropscience Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-15

Filing date

2000-11-13

Publication date

2002-01-14

2000-11-13 Application filed by Aventis Cropscience Sa filed Critical Aventis Cropscience Sa

2002-01-14 Publication of ZA200006567B publication Critical patent/ZA200006567B/en

Links

108090000623 proteins and genes Proteins 0.000 title claims description 72
108090000765 processed proteins & peptides Proteins 0.000 claims description 147
241000196324 Embryophyta Species 0.000 claims description 96
235000001014 amino acid Nutrition 0.000 claims description 55
150000001413 amino acids Chemical class 0.000 claims description 52
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 39
239000012634 fragment Substances 0.000 claims description 31
230000014509 gene expression Effects 0.000 claims description 28
108020004414 DNA Proteins 0.000 claims description 23
108010076504 Protein Sorting Signals Proteins 0.000 claims description 19
241000233866 Fungi Species 0.000 claims description 18
239000000203 mixture Substances 0.000 claims description 17
244000061176 Nicotiana tabacum Species 0.000 claims description 14
235000002637 Nicotiana tabacum Nutrition 0.000 claims description 14
230000004927 fusion Effects 0.000 claims description 14
108091026890 Coding region Proteins 0.000 claims description 13
150000007523 nucleic acids Chemical group 0.000 claims description 13
230000001105 regulatory effect Effects 0.000 claims description 13
241000894006 Bacteria Species 0.000 claims description 12
102000004196 processed proteins & peptides Human genes 0.000 claims description 11
238000010367 cloning Methods 0.000 claims description 8
244000005700 microbiome Species 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
240000008042 Zea mays Species 0.000 claims description 6
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 6
235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
230000002378 acidificating effect Effects 0.000 claims description 6
235000009973 maize Nutrition 0.000 claims description 6
108020005091 Replication Origin Proteins 0.000 claims description 5
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 5
101150104606 pgl gene Proteins 0.000 claims description 5
239000004475 Arginine Substances 0.000 claims description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
239000003814 drug Substances 0.000 claims description 4
108010059820 Polygalacturonase Proteins 0.000 claims description 3
150000007513 acids Chemical class 0.000 claims description 3
239000002773 nucleotide Substances 0.000 claims description 3
125000003729 nucleotide group Chemical group 0.000 claims description 3
239000002243 precursor Substances 0.000 claims description 3
235000003704 aspartic acid Nutrition 0.000 claims description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
230000008685 targeting Effects 0.000 claims description 2
241000701447 unidentified baculovirus Species 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims 2
JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 claims 1
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 63
108091034117 Oligonucleotide Proteins 0.000 description 39
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 38
238000000034 method Methods 0.000 description 36
239000013612 plasmid Substances 0.000 description 34
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 28
239000013598 vector Substances 0.000 description 28
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 27
210000004027 cell Anatomy 0.000 description 24
230000000843 anti-fungal effect Effects 0.000 description 20
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
230000000694 effects Effects 0.000 description 19
239000000243 solution Substances 0.000 description 19
230000009466 transformation Effects 0.000 description 18
239000012071 phase Substances 0.000 description 16
235000018102 proteins Nutrition 0.000 description 16
102000004169 proteins and genes Human genes 0.000 description 16
238000012360 testing method Methods 0.000 description 16
108091008146 restriction endonucleases Proteins 0.000 description 15
238000000746 purification Methods 0.000 description 14
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 12
239000002609 medium Substances 0.000 description 12
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
201000010099 disease Diseases 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
241000589155 Agrobacterium tumefaciens Species 0.000 description 10
239000013543 active substance Substances 0.000 description 10
230000000295 complement effect Effects 0.000 description 10
229910021642 ultra pure water Inorganic materials 0.000 description 10
239000012498 ultrapure water Substances 0.000 description 10
230000000855 fungicidal effect Effects 0.000 description 9
210000000087 hemolymph Anatomy 0.000 description 9
239000000047 product Substances 0.000 description 9
230000000844 anti-bacterial effect Effects 0.000 description 8
229940121375 antifungal agent Drugs 0.000 description 8
239000000872 buffer Substances 0.000 description 8
238000005119 centrifugation Methods 0.000 description 8
239000000284 extract Substances 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
239000003643 water by type Substances 0.000 description 8
238000002835 absorbance Methods 0.000 description 7
230000002538 fungal effect Effects 0.000 description 7
239000001963 growth medium Substances 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
230000001131 transforming effect Effects 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
241000256244 Heliothis virescens Species 0.000 description 6
239000002585 base Substances 0.000 description 6
108020001507 fusion proteins Proteins 0.000 description 6
102000037865 fusion proteins Human genes 0.000 description 6
239000004009 herbicide Substances 0.000 description 6
238000004128 high performance liquid chromatography Methods 0.000 description 6
238000009396 hybridization Methods 0.000 description 6
239000007788 liquid Substances 0.000 description 6
-1 polypropylene Polymers 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
230000009261 transgenic effect Effects 0.000 description 6
238000005406 washing Methods 0.000 description 6
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 5
239000005695 Ammonium acetate Substances 0.000 description 5
108020004705 Codon Proteins 0.000 description 5
102000004594 DNA Polymerase I Human genes 0.000 description 5
108010017826 DNA Polymerase I Proteins 0.000 description 5
208000031888 Mycoses Diseases 0.000 description 5
235000019257 ammonium acetate Nutrition 0.000 description 5
229940043376 ammonium acetate Drugs 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
238000010828 elution Methods 0.000 description 5
238000012544 monitoring process Methods 0.000 description 5
238000002414 normal-phase solid-phase extraction Methods 0.000 description 5
239000000843 powder Substances 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
239000006152 selective media Substances 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
239000000080 wetting agent Substances 0.000 description 5
UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 4
239000005489 Bromoxynil Substances 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
241000223194 Fusarium culmorum Species 0.000 description 4
241000221961 Neurospora crassa Species 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
241000723792 Tobacco etch virus Species 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
239000012190 activator Substances 0.000 description 4
239000012872 agrochemical composition Substances 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000002270 dispersing agent Substances 0.000 description 4
230000001747 exhibiting effect Effects 0.000 description 4
210000002744 extracellular matrix Anatomy 0.000 description 4
238000000605 extraction Methods 0.000 description 4
239000008187 granular material Substances 0.000 description 4
239000003550 marker Substances 0.000 description 4
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 4
230000008488 polyadenylation Effects 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000028327 secretion Effects 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
238000001228 spectrum Methods 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
238000011282 treatment Methods 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
241000123650 Botrytis cinerea Species 0.000 description 3
241001515826 Cassava vein mosaic virus Species 0.000 description 3
241000701489 Cauliflower mosaic virus Species 0.000 description 3
101000844746 Drosophila melanogaster Drosomycin Proteins 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
244000068988 Glycine max Species 0.000 description 3
235000010469 Glycine max Nutrition 0.000 description 3
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 3
108700001094 Plant Genes Proteins 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
108090001109 Thermolysin Proteins 0.000 description 3
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 3
241000209140 Triticum Species 0.000 description 3
235000021307 Triticum Nutrition 0.000 description 3
239000003929 acidic solution Substances 0.000 description 3
230000009471 action Effects 0.000 description 3
230000002051 biphasic effect Effects 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
238000005341 cation exchange Methods 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000012258 culturing Methods 0.000 description 3
150000002191 fatty alcohols Chemical class 0.000 description 3
239000000945 filler Substances 0.000 description 3
230000001408 fungistatic effect Effects 0.000 description 3
150000002433 hydrophilic molecules Chemical class 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
238000002955 isolation Methods 0.000 description 3
229930027917 kanamycin Natural products 0.000 description 3
229960000318 kanamycin Drugs 0.000 description 3
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
229930182823 kanamycin A Natural products 0.000 description 3
238000004949 mass spectrometry Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
108010058731 nopaline synthase Proteins 0.000 description 3
230000025540 plastid localization Effects 0.000 description 3
239000013641 positive control Substances 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000008929 regeneration Effects 0.000 description 3
238000011069 regeneration method Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
238000004366 reverse phase liquid chromatography Methods 0.000 description 3
230000007017 scission Effects 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
DMAXMXPDVWTIRV-UHFFFAOYSA-N 2-(2-phenylethyl)phenol Chemical class OC1=CC=CC=C1CCC1=CC=CC=C1 DMAXMXPDVWTIRV-UHFFFAOYSA-N 0.000 description 2
UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
101710120040 Antifungal peptide Proteins 0.000 description 2
108700042778 Antimicrobial Peptides Proteins 0.000 description 2
102000044503 Antimicrobial Peptides Human genes 0.000 description 2
241001225321 Aspergillus fumigatus Species 0.000 description 2
125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
241000222122 Candida albicans Species 0.000 description 2
241000222178 Candida tropicalis Species 0.000 description 2
201000007336 Cryptococcosis Diseases 0.000 description 2
241000221204 Cryptococcus neoformans Species 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
241000223218 Fusarium Species 0.000 description 2
241000223221 Fusarium oxysporum Species 0.000 description 2
108700007698 Genetic Terminator Regions Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
244000020551 Helianthus annuus Species 0.000 description 2
235000003222 Helianthus annuus Nutrition 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
240000005979 Hordeum vulgare Species 0.000 description 2
235000007340 Hordeum vulgare Nutrition 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
DEFJQIDDEAULHB-IMJSIDKUSA-N L-alanyl-L-alanine Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(O)=O DEFJQIDDEAULHB-IMJSIDKUSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
241001226034 Nectria <echinoderm> Species 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
241000235645 Pichia kudriavzevii Species 0.000 description 2
239000004365 Protease Substances 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
240000003768 Solanum lycopersicum Species 0.000 description 2
108700005078 Synthetic Genes Proteins 0.000 description 2
241000723873 Tobacco mosaic virus Species 0.000 description 2
241000223261 Trichoderma viride Species 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
241000509563 [Candida] inconspicua Species 0.000 description 2
241001231403 [Nectria] haematococca Species 0.000 description 2
239000008272 agar Substances 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
108010056243 alanylalanine Proteins 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
229940091771 aspergillus fumigatus Drugs 0.000 description 2
230000003385 bacteriostatic effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
229940095731 candida albicans Drugs 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
210000003763 chloroplast Anatomy 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
239000000470 constituent Substances 0.000 description 2
244000038559 crop plants Species 0.000 description 2
239000000287 crude extract Substances 0.000 description 2
238000001514 detection method Methods 0.000 description 2
230000014155 detection of activity Effects 0.000 description 2
210000002472 endoplasmic reticulum Anatomy 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
229940102223 injectable solution Drugs 0.000 description 2
238000011005 laboratory method Methods 0.000 description 2
238000001819 mass spectrum Methods 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
238000000765 microspectrophotometry Methods 0.000 description 2
230000035772 mutation Effects 0.000 description 2
230000017066 negative regulation of growth Effects 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
150000007524 organic acids Chemical group 0.000 description 2
244000052769 pathogen Species 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
239000003910 polypeptide antibiotic agent Substances 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
239000001965 potato dextrose agar Substances 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
230000006337 proteolytic cleavage Effects 0.000 description 2
239000012429 reaction media Substances 0.000 description 2
238000004007 reversed phase HPLC Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
PQMRRAQXKWFYQN-UHFFFAOYSA-N 1-phenyl-2-sulfanylideneimidazolidin-4-one Chemical class S=C1NC(=O)CN1C1=CC=CC=C1 PQMRRAQXKWFYQN-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 1
HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
241000193798 Aerococcus Species 0.000 description 1
241000193792 Aerococcus viridans Species 0.000 description 1
241000589156 Agrobacterium rhizogenes Species 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
101710185380 Androctonin Proteins 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
241000228212 Aspergillus Species 0.000 description 1
101150075884 BRX gene Proteins 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000194107 Bacillus megaterium Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
235000016068 Berberis vulgaris Nutrition 0.000 description 1
241000335053 Beta vulgaris Species 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
244000197813 Camelina sativa Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
241001157813 Cercospora Species 0.000 description 1
241000530549 Cercospora beticola Species 0.000 description 1
241000222290 Cladosporium Species 0.000 description 1
241001149956 Cladosporium herbarum Species 0.000 description 1
241001442234 Cosa Species 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
241001362614 Crassa Species 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 1
101710164770 Drosomycin Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
241000223195 Fusarium graminearum Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000219146 Gossypium Species 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
241000256257 Heliothis Species 0.000 description 1
108700022013 Insecta cecropin B Proteins 0.000 description 1
208000037026 Invasive Fungal Infections Diseases 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
241000588744 Klebsiella pneumoniae subsp. ozaenae Species 0.000 description 1
241000235649 Kluyveromyces Species 0.000 description 1
QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
LCPYQJIKPJDLLB-UWVGGRQHSA-N Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C LCPYQJIKPJDLLB-UWVGGRQHSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000192041 Micrococcus Species 0.000 description 1
241000191938 Micrococcus luteus Species 0.000 description 1
244000128833 Mimulus luteus Species 0.000 description 1
101100364971 Mus musculus Scai gene Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
241001443590 Naganishia albida Species 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
102000004020 Oxygenases Human genes 0.000 description 1
108090000417 Oxygenases Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
241000233614 Phytophthora Species 0.000 description 1
241000233618 Phytophthora cinnamomi Species 0.000 description 1
241000235648 Pichia Species 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
101710127332 Protease I Proteins 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
240000000111 Saccharum officinarum Species 0.000 description 1
235000007201 Saccharum officinarum Nutrition 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
239000003849 aromatic solvent Substances 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
210000004900 c-terminal fragment Anatomy 0.000 description 1
229920005551 calcium lignosulfonate Polymers 0.000 description 1
244000309466 calf Species 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
229960004261 cefotaxime Drugs 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
239000004927 clay Substances 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
RVGAEGHWOZOGRZ-UHFFFAOYSA-N cyclohexanone;oxirane Chemical compound C1CO1.O=C1CCCCC1 RVGAEGHWOZOGRZ-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
238000003795 desorption Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000004495 emulsifiable concentrate Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000003053 immunization Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
108010091798 leucylleucine Proteins 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
239000006870 ms-medium Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical class CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000029553 photosynthesis Effects 0.000 description 1
238000010672 photosynthesis Methods 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000151 polyglycol Polymers 0.000 description 1
239000010695 polyglycol Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000002601 radiography Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
239000012882 rooting medium Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229920005552 sodium lignosulfonate Polymers 0.000 description 1
239000002689 soil Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000012795 verification Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Insects & Arthropods (AREA)
Pest Control & Pesticides (AREA)
Agronomy & Crop Science (AREA)
Plant Pathology (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA200006567A 1998-04-15 2000-11-13 Gene coding for heliomicine and use thereof. ZA200006567B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9804933A FR2777568B1 (fr)	1998-04-15	1998-04-15	Gene codant pour l'heliomicine, proteine obtenue, vecteur le contenant, organismes transformes obtenus et procede de preparation

Publications (1)

Publication Number	Publication Date
ZA200006567B true ZA200006567B (en)	2002-01-14

Family

ID=9525455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200006567A ZA200006567B (en)	1998-04-15	2000-11-13	Gene coding for heliomicine and use thereof.

Country Status (24)

Country	Link
US (1)	US6916782B1 (cs)
EP (1)	EP1071767B1 (cs)
JP (1)	JP2002511260A (cs)
KR (1)	KR20010042735A (cs)
CN (1)	CN1305526A (cs)
AR (1)	AR019066A1 (cs)
AT (1)	ATE366811T1 (cs)
AU (1)	AU754856B2 (cs)
BR (1)	BR9909745A (cs)
CA (1)	CA2325658A1 (cs)
CY (1)	CY1106926T1 (cs)
CZ (1)	CZ297645B6 (cs)
DE (1)	DE69936514T2 (cs)
DK (1)	DK1071767T3 (cs)
ES (1)	ES2291021T3 (cs)
FR (1)	FR2777568B1 (cs)
HU (1)	HU225803B1 (cs)
IL (1)	IL139011A0 (cs)
NO (1)	NO20005173L (cs)
PL (1)	PL198979B1 (cs)
PT (1)	PT1071767E (cs)
TR (1)	TR200002989T2 (cs)
WO (1)	WO1999053053A1 (cs)
ZA (1)	ZA200006567B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2810993B1 (fr) *	2000-06-29	2002-08-23	Rhobio	Peptides antimicrobiens de la famille des defensines, polynucleotides codant ces peptides, vecteurs et organismes transformes les contenant
FR2811665B1 (fr) *	2000-07-13	2002-10-18	Entomed S A	Peptides antifongiques et/ou antibacteriens, leurs preparations et les compositions les contenant
FR2811666B1 (fr) *	2000-07-13	2005-04-01	Entomed S A	Peptides antifongiques et/ou antibacteriens, leurs preparations et les compositions les contenant
US6891085B2 (en)	2001-04-20	2005-05-10	Pioneer Hi-Bred International, Inc.	Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
DE60215534T2 (de) *	2001-11-20	2007-09-20	Novozymes A/S	Antimikrobielle polypeptide aus pseudoplectania nigrella
FR2844142B1 (fr)	2002-09-11	2007-08-17	Bayer Cropscience Sa	Plantes transformees a biosynthese de prenylquinones amelioree
FR2848571A1 (fr) *	2002-12-12	2004-06-18	Bayer Cropscience Sa	Cassette d'expression codant pour une hydroxy-phenyl pyruvate dioxygenase et plantes contenant un tel gene tolerantes aux herbicides
FR2848570B1 (fr) *	2002-12-12	2005-04-01	Bayer Cropscience Sa	Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant
WO2006053565A2 (en)	2004-11-19	2006-05-26	Novozymes A/S	Polypeptides having antimicrobial activity and polynucleotides encoding same
US7485619B2 (en) *	2005-01-31	2009-02-03	Yeon Sook KIM	Antimicrobial agent
CN101142231A (zh)	2005-03-16	2008-03-12	诺维信公司	在丝状真菌中重组表达防卫素
AR052947A1 (es)	2005-03-18	2007-04-11	Novozymes As	Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican para los mismos
US7130534B1 (en) *	2005-04-21	2006-10-31	Agilent Technologies, Inc.	Gas chromatograph having a radiant oven for analytical devices
ES2548763T3 (es)	2007-01-11	2015-10-20	Bayer Cropscience Nv	Expresión diferencial de alelos específicos de subgenoma en algodón y usos de los mismos
EP2132319B1 (en)	2007-02-23	2012-08-01	Novozymes Adenium Biotech A/S	Method for producing an antifungal peptide in a filamentous fungal host cell
AR074941A1 (es)	2009-01-07	2011-02-23	Bayer Cropscience Sa	Plantas transplastomicas exentas de marcador de seleccion
US20120311743A1 (en)	2010-02-02	2012-12-06	Bayer Cropscience Ag	Soybean transformation using hppd inhibitors as selection agents
WO2011104284A1 (en)	2010-02-25	2011-09-01	Novozymes A/S	Polypeptides having antimicrobial activity
US9080161B2 (en)	2011-01-26	2015-07-14	Novozymes, Inc.	Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
US10036050B2 (en)	2011-12-20	2018-07-31	Novozymes, Inc.	Cellobiohydrolase variants and polynucleotides encoding same
US11034742B2 (en)	2017-07-17	2021-06-15	Linnane Pharma Ab	Peptides with antibiotic potential against Mycobacterium tuberculosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU350364A1 (ru) *	1971-03-17	1973-10-19	Институт изысканию новых антибиотиков АМН СССР	Продуцент гелиомицина
ZA885916B (en) *	1987-09-15	1989-04-26	Gen Hospital Corp	Pathogenesis-related proteins in plants
WO1990011770A1 (en) *	1989-04-11	1990-10-18	Calgene, Inc.	Use of animal-derived anti-microbial peptides for control of plant pathogens
FR2695392B1 (fr) *	1992-09-04	1994-10-14	Centre Nat Rech Scient	Peptides possédant notamment des propriétés antibactériennes, leur procédé d'obtention, et leurs applications biologiques.
FR2700338B1 (fr) *	1993-01-11	1995-03-31	Transgene Sa	Nouvelle séquence pro permettant la secrétion de protéines hétérologues à partir d'une cellule de levure.
FR2725992A1 (fr) *	1994-10-25	1996-04-26	Rhone Poulenc Agrochimie	Peptide antifongique
FR2745004B1 (fr) *	1996-02-16	1998-03-27	Rhone Poulenc Agrochimie	Peptide antibacterien et antifongique
FR2766207B1 (fr) *	1997-07-11	2000-12-08	Rhone Poulenc Agrochimie	Gene chimere codant pour la drosomycine, vecteur le contenant pour la transformation des cellules vegetales et plantes transformees obtenues resistantes aux maladies

1998
- 1998-04-15 FR FR9804933A patent/FR2777568B1/fr not_active Expired - Lifetime
1999
- 1999-04-12 AU AU31525/99A patent/AU754856B2/en not_active Ceased
- 1999-04-12 BR BR9909745-1A patent/BR9909745A/pt not_active IP Right Cessation
- 1999-04-12 CZ CZ20003785A patent/CZ297645B6/cs not_active IP Right Cessation
- 1999-04-12 TR TR2000/02989T patent/TR200002989T2/xx unknown
- 1999-04-12 PL PL345243A patent/PL198979B1/pl not_active IP Right Cessation
- 1999-04-12 PT PT99913384T patent/PT1071767E/pt unknown
- 1999-04-12 HU HU0102302A patent/HU225803B1/hu not_active IP Right Cessation
- 1999-04-12 DK DK99913384T patent/DK1071767T3/da active
- 1999-04-12 ES ES99913384T patent/ES2291021T3/es not_active Expired - Lifetime
- 1999-04-12 WO PCT/FR1999/000843 patent/WO1999053053A1/fr not_active Ceased
- 1999-04-12 JP JP2000543601A patent/JP2002511260A/ja not_active Withdrawn
- 1999-04-12 KR KR1020007011459A patent/KR20010042735A/ko not_active Withdrawn
- 1999-04-12 AT AT99913384T patent/ATE366811T1/de not_active IP Right Cessation
- 1999-04-12 DE DE69936514T patent/DE69936514T2/de not_active Expired - Fee Related
- 1999-04-12 CN CN99807258A patent/CN1305526A/zh active Pending
- 1999-04-12 IL IL13901199A patent/IL139011A0/xx unknown
- 1999-04-12 US US09/673,274 patent/US6916782B1/en not_active Expired - Fee Related
- 1999-04-12 CA CA002325658A patent/CA2325658A1/fr not_active Abandoned
- 1999-04-12 EP EP99913384A patent/EP1071767B1/fr not_active Expired - Lifetime
- 1999-04-14 AR ARP990101719A patent/AR019066A1/es unknown
2000
- 2000-10-13 NO NO20005173A patent/NO20005173L/no not_active Application Discontinuation
- 2000-11-13 ZA ZA200006567A patent/ZA200006567B/en unknown
2007
- 2007-10-11 CY CY20071101306T patent/CY1106926T1/el unknown

Also Published As

Publication number	Publication date
AR019066A1 (es)	2001-12-26
AU754856B2 (en)	2002-11-28
BR9909745A (pt)	2000-12-26
EP1071767A1 (fr)	2001-01-31
CZ297645B6 (cs)	2007-02-21
JP2002511260A (ja)	2002-04-16
EP1071767B1 (fr)	2007-07-11
CY1106926T1 (el)	2012-09-26
CN1305526A (zh)	2001-07-25
DE69936514T2 (de)	2008-03-20
DE69936514D1 (de)	2007-08-23
TR200002989T2 (tr)	2000-12-21
FR2777568A1 (fr)	1999-10-22
ES2291021T3 (es)	2008-02-16
KR20010042735A (ko)	2001-05-25
DK1071767T3 (da)	2007-11-05
US6916782B1 (en)	2005-07-12
NO20005173D0 (no)	2000-10-13
PT1071767E (pt)	2007-10-23
CA2325658A1 (fr)	1999-10-21
CZ20003785A3 (cs)	2001-03-14
ATE366811T1 (de)	2007-08-15
PL345243A1 (en)	2001-12-03
HU225803B1 (en)	2007-09-28
HUP0102302A3 (en)	2003-03-28
NO20005173L (no)	2000-12-15
PL198979B1 (pl)	2008-08-29
WO1999053053A1 (fr)	1999-10-21
AU3152599A (en)	1999-11-01
HUP0102302A2 (hu)	2001-09-28
FR2777568B1 (fr)	2002-10-31
IL139011A0 (en)	2001-11-25

Publication	Publication Date	Title
US6916782B1 (en)	2005-07-12	Gene coding for heliomicine and use thereof
CA2128250C (en)	1999-11-30	Insecticidally effective peptides
JP2001510995A (ja)	2001-08-07	抗微生物性タンパク質
CN101284876A (zh)	2008-10-15	融合蛋白Penharpin及制备方法和用途
AU739137B2 (en)	2001-10-04	Chimeric gene encoding drosomycin, vector containing it and production of disease-resistant transgenic plants
US20130219532A1 (en)	2013-08-22	Peptides with antifungal activities
KR102171336B1 (ko)	2020-10-28	식물 병원성 진균에 대항하는 폴리펩티드
KR101481902B1 (ko)	2015-01-14	항균 및 항진균 활성을 갖는 신규 폴리펩티드
US20080032924A1 (en)	2008-02-07	Antifungal Peptides
CN120731217A (zh)	2025-09-30	抗微生物肽及其修饰
CN1634981B (zh)	2010-06-16	一组新的抗菌肽及其制备方法和应用
US20040087771A1 (en)	2004-05-06	Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them
CN101649321B (zh)	2011-03-23	东北天南星凝集素蛋白编码序列及其应用
CN102391364B (zh)	2013-07-17	一种抗菌肽及其制备方法和应用
CN101781358B (zh)	2012-08-08	一组新的抗菌肽及其制备方法和应用
AU9076698A (en)	1999-03-08	Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
US20030208035A1 (en)	2003-11-06	Antifungal and/or antibacterial peptides, preparation methods, compositions containing same and methods of treating mammals and/or plants
CN101781366B (zh)	2012-08-08	一组新的抗菌肽及其制备方法和应用
CN102391365B (zh)	2013-07-17	一种抗菌肽及其制备方法和应用
JPWO2003033532A1 (ja)	2005-02-03	抗微生物蛋白質、それをコードする遺伝子及びそれらの利用法
CN102391370A (zh)	2012-03-28	一组新的抗菌肽及其制备方法和应用
AU2012201612A1 (en)	2012-04-05	Antifungal peptides
AU2005215825A1 (en)	2005-09-01	Antifungal peptides